A detailed history of Bellevue Group Ag transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Bellevue Group Ag holds 70,821 shares of TEVA stock, worth $1.21 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
70,821
Previous 154,770 54.24%
Holding current value
$1.21 Million
Previous $2.52 Million 49.26%
% of portfolio
0.02%
Previous 0.04%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$15.81 - $18.96 $1.33 Million - $1.59 Million
-83,949 Reduced 54.24%
70,821 $1.28 Million
Q2 2024

Aug 14, 2024

BUY
$12.78 - $17.4 $160,478 - $218,491
12,557 Added 8.83%
154,770 $2.52 Million
Q1 2024

May 15, 2024

BUY
$10.67 - $14.43 $1.52 Million - $2.05 Million
142,213 New
142,213 $2.01 Million
Q2 2020

Aug 13, 2020

SELL
$8.12 - $13.12 $2.46 Million - $3.98 Million
-303,000 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$6.69 - $13.45 $247,530 - $497,650
37,000 Added 13.91%
303,000 $2.72 Million
Q4 2019

Feb 14, 2020

BUY
$6.53 - $10.72 $757,480 - $1.24 Million
116,000 Added 77.33%
266,000 $2.61 Million
Q3 2019

Nov 14, 2019

BUY
$6.16 - $9.6 $924,000 - $1.44 Million
150,000 New
150,000 $1.03 Million
Q1 2019

May 15, 2019

SELL
$15.58 - $20.01 $934,800 - $1.2 Million
-60,000 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$21.06 - $25.65 $631,800 - $769,500
-30,000 Reduced 33.33%
60,000 $1.29 Million
Q1 2018

May 09, 2018

SELL
$16.68 - $22.07 $9.71 Million - $12.8 Million
-581,940 Reduced 86.61%
90,000 $1.54 Million
Q4 2017

Feb 14, 2018

BUY
$11.23 - $19.1 $1.01 Million - $1.72 Million
90,000 Added 15.47%
671,940 $12.7 Million
Q3 2017

Nov 13, 2017

BUY
$15.41 - $32.17 $4.57 Million - $9.54 Million
296,611 Added 103.95%
581,940 $10.2 Million
Q2 2017

Aug 14, 2017

BUY
N/A
285,329
285,329 $9.48 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.